Challenges in preclinical to clinical translation for anticancer carrier-mediated agents
出版年份 2016 全文链接
标题
Challenges in preclinical to clinical translation for anticancer carrier-mediated agents
作者
关键词
-
出版物
Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
Volume 8, Issue 5, Pages 642-653
出版商
Wiley
发表日期
2016-02-05
DOI
10.1002/wnan.1394
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Risk factors for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia over time: assessment of monocyte count and baseline clinical parameters
- (2015) Zahra Ajgal et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
- (2015) Edgar Pérez-Herrero et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents
- (2015) Andrew T Lucas et al. Expert Opinion on Drug Metabolism & Toxicology
- The effects of nanoparticle drug loading on the pharmacokinetics of anticancer agents
- (2015) Jennifer S Petschauer et al. Nanomedicine
- Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer
- (2015) Gina Song et al. Nanomedicine-Nanotechnology Biology and Medicine
- Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models
- (2014) G. Song et al. CLINICAL CANCER RESEARCH
- Targeted therapy using nanotechnology: focus on cancer
- (2014) Mario Sechi et al. International Journal of Nanomedicine
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- A Review of Study Designs and Outcomes of Phase I Clinical Studies of Nanoparticle Agents Compared with Small-Molecule Anticancer Agents
- (2013) W. P. Caron et al. CLINICAL CANCER RESEARCH
- Meta-analysis of inter-patient pharmacokinetic variability of liposomal and non-liposomal anticancer agents
- (2013) Ryan F. Schell et al. Nanomedicine-Nanotechnology Biology and Medicine
- Challenges in Development of Nanoparticle-Based Therapeutics
- (2012) Neil Desai AAPS Journal
- Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research
- (2012) Susana Patricia Egusquiaguirre et al. Clinical & Translational Oncology
- Interpatient Pharmacokinetic and Pharmacodynamic Variability of Carrier-Mediated Anticancer Agents
- (2012) W P Caron et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs
- (2012) Takuya Suzuki et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The big picture on nanomedicine: the state of investigational and approved nanomedicine products
- (2012) Michael L. Etheridge et al. Nanomedicine-Nanotechnology Biology and Medicine
- Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients
- (2011) Ninh M. La-Beck et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Allometric scaling of pegylated liposomal anticancer drugs
- (2011) Whitney P. Caron et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Translational considerations for cancer nanomedicine
- (2010) Stephan T. Stern et al. JOURNAL OF CONTROLLED RELEASE
- Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumors
- (2010) William C. Zamboni et al. JOURNAL OF LIPOSOME RESEARCH
- Phase I and Pharmacokinetic Study of Pegylated Liposomal CKD-602 in Patients with Advanced Malignancies
- (2009) W. C. Zamboni et al. CLINICAL CANCER RESEARCH
- In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts
- (2009) Jean Y Perentes et al. NATURE METHODS
- Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle Biodistribution
- (2008) Marina A. Dobrovolskaia et al. MOLECULAR PHARMACEUTICS
- Concept and Clinical Evaluation of Carrier-Mediated Anticancer Agents
- (2008) W. C. Zamboni ONCOLOGIST
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More